Scientists talking to the public or media should refer to LifeArc for further information before engaging. Details of MRC-owned Intellectual Property (IP), such as research results, must be kept confidential and not disclosed to any third party without adequate consideration being given to its potential commercial value. Disclosure may severely prejudice the MRC or third parties’ ability to exploit it in the development of novel treatments, devices, etc. thereby having a negative impact on the MRC’s mission to improve human health.
Individuals working in MRC establishments should seek the advice of MRCT or local technology transfer staff before considering any type of IP disclosure so that, if necessary, a confidential disclosure agreement may be put in place or a patent application filed.